Moreover, EN1-iPeps have been found to inhibit EN1’s role in activating intrinsic inflammatory pathways associated with tumor survival, which is particularly relevant in basal breast cancer, a subtype of breast cancer known for its aggressive behavior and poor prognosis [111] (see Figure 1). This evidence concerns the gene EN1 and breast cancer.